Literature DB >> 27178273

The dark side of the moon of coronary vasodilation.

Raffaele Giubbini1, Francesco Bertagna2.   

Abstract

Mesh：

Year:  2016        PMID： 27178273     DOI： 10.1007/s00259-016-3416-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  10 in total

1.  PERSANTIN-- A DOUBLE BLIND STUDY.

Authors:  A LEIBERMAN; S GUGLIELMELLI
Journal:  Angiology       Date:  1964-06       Impact factor: 3.619

2.  A LONG-TERM THERAPY OF ISCHEMIC HEART DISEASE.

Authors:  A H GRIEP
Journal:  Angiology       Date:  1963-09       Impact factor: 3.619

3.  Controlled double-blind trial of "persantin" in treatment of angina pectoris.

Authors:  T FOULDS; J MACKINNON
Journal:  Br Med J       Date:  1960-09-17

4.  Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.

Authors:  Hsiao D Lieu; John C Shryock; Gregory O von Mering; Toufigh Gordi; Brent Blackburn; Ann W Olmsted; Luiz Belardinelli; Richard A Kerensky
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

5.  Effect of dipyridamole on human platelet behaviour.

Authors:  P R Emmons; M J Harrison; A J Honour; J R Mitchell
Journal:  Lancet       Date:  1965-09-25       Impact factor: 79.321

6.  Dipyridamole in long-term treatment of coronary insufficiency.

Authors:  C G Gaddy
Journal:  Va Med Mon (1918)       Date:  1966-06

7.  Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit.

Authors:  P R Emmons; M J Harrison; A J Honour; J R Mitchell
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

8.  Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats.

Authors:  Arvinder K Dhalla; Mei-Yee Wong; Wei-Qun Wang; Italo Biaggioni; Luiz Belardinelli
Journal:  J Pharmacol Exp Ther       Date:  2005-10-14       Impact factor: 4.030

9.  Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.

Authors:  Fahad M Iqbal; Wael Al Jaroudi; Kumar Sanam; Aaron Sweeney; Jaekyeong Heo; Ami E Iskandrian; Fadi G Hage
Journal:  Am J Cardiol       Date:  2012-10-27       Impact factor: 2.778

10.  The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.

Authors:  Efstathia Andrikopoulou; Wael A AlJaroudi; Ayman Farag; Davis Lester; Hiren Patel; Ami E Iskandrian; Fadi G Hage
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-15       Impact factor: 9.236
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.